Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicorandil for early intervention of ventricular arrhythmia after acute STEMI
ChiCTR2500104685Phase 4Recruiting
- Sponsor
- Chongqing Emergency Medical Center
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nicorandil in acute ST-segment elevation myocardial infarction (STEMI) and ventricular arrhythmia (VA) (2 arms), sponsored by Chongqing Emergency Medical Center. Primary endpoint: Incidence of ventricular arrhythmias. Started Jun 2025; status: recruiting.
02
Drugs
nicorandil
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)ventricular arrhythmia (VA)
Beyond the preview
Go deeper on ChiCTR2500104685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104685.